Blood pressure medication recalled for potential ineffectiveness
A nationwide recall affects 11,460 bottles of the blood pressure drug chlorthalidone. Testing indicates the medication may not dissolve properly. This manufacturing defect could make the drug ineffective.
What changed
The total number of recalled bottles is now specified as 11,460.
Live updates
-
FDA Recalls 11,460 Bottles of Chlorthalidone for Dissolution Issues
confidence 100%A nationwide recall affects 11,460 bottles of the blood pressure drug chlorthalidone. Testing indicates the medication may not dissolve properly. This manufacturing defect could make the drug ineffective.
What's confirmed:
- A nationwide recall has been issued for 11,460 bottles of chlorthalidone.
- Testing showed the blood pressure medication may not dissolve properly.
-
FDA Recalls 11,460 Bottles of Chlorthalidone Blood Pressure Tablets
confidence 100%The FDA has issued a nationwide recall of chlorthalidone blood pressure medication. The recall involves more than 11,000 bottles due to a manufacturing issue that may render the drug ineffective. The problem is linked to a possible dissolution failure.
What's confirmed:
- The FDA issued a nationwide recall of chlorthalidone blood pressure tablets.
- The recall affects 11,460 bottles of the medication.
- The medication may be ineffective due to a dissolution issue.
- Rising Pharma Holdings Inc. of New Jersey distributed the affected 100-count and 1,000-count bottles in the United States.